Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Joseph

Showing results (221-230 of 267) with videos related to

Pageof 27
Sort By:
BMJ Open|May 11, 2021
Geriatric fracture centre vs usual care after proximal femur fracture in older patients: what are the benefits? Results of a large international prospective multicentre studyMichael Blauth, Alexander Joeris, Elke Rometsch, et al.
The Lancet. Oncology|December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trialJames W Denham, David Joseph, David S Lamb, et al.
BMJ Open|November 2, 2023
Cost-effectiveness analysis of the Geriatric Fracture Center (GFC) concept: a prospective multicentre cohort studyAlexander Joeris, Sheila Sprague, Michael Blauth, et al.
The Lancet. Oncology|November 1, 2005
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trialJames W Denham, Allison Steigler, David S Lamb, et al.
The Journal of Urology|December 9, 2024
Diagnostic Test Characteristics of Ultrasound-Based Hydronephrosis for Chronic Kidney Disease in Children and Adolescents With Myelomeningocele: Results From the UMPIRE and National Spina Bifida Patient Registry Cohort StudiesDavid I Chu, Tiebin Liu, Tonya Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Disease Models & Mechanisms|April 25, 2022
The benefits, limitations and opportunities of preclinical models for neonatal drug developmentSarah Campion, Amy Inselman, Belinda Hayes, et al.
Archives of Endocrinology and Metabolism|May 1, 2015
Risk factors associated with hypovitaminosis D in HIV/aids-infected adultsJuliana Maria Palmeira Canuto, Virginia Maria Palmeira Canuto, Matheus Henrique Alves de Lima, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2003
Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancerDavid S Lamb, James W Denham, Hedy Mameghan, et al.
Pageof 27

Showing results (221-230 of 267) with videos related to

Sort By:
Pageof 27
BMJ Open|May 11, 2021
Geriatric fracture centre vs usual care after proximal femur fracture in older patients: what are the benefits? Results of a large international prospective multicentre studyMichael Blauth, Alexander Joeris, Elke Rometsch, et al.
The Lancet. Oncology|December 24, 2018
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trialJames W Denham, David Joseph, David S Lamb, et al.
The Lancet. Oncology|August 19, 2014
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trialJames W Denham, David Joseph, David S Lamb, et al.
BMJ Open|November 2, 2023
Cost-effectiveness analysis of the Geriatric Fracture Center (GFC) concept: a prospective multicentre cohort studyAlexander Joeris, Sheila Sprague, Michael Blauth, et al.
The Lancet. Oncology|November 1, 2005
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trialJames W Denham, Allison Steigler, David S Lamb, et al.
The Journal of Urology|December 9, 2024
Diagnostic Test Characteristics of Ultrasound-Based Hydronephrosis for Chronic Kidney Disease in Children and Adolescents With Myelomeningocele: Results From the UMPIRE and National Spina Bifida Patient Registry Cohort StudiesDavid I Chu, Tiebin Liu, Tonya Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADARWee Loon Ong, John Nikitas, David Joseph, et al.
Disease Models & Mechanisms|April 25, 2022
The benefits, limitations and opportunities of preclinical models for neonatal drug developmentSarah Campion, Amy Inselman, Belinda Hayes, et al.
Archives of Endocrinology and Metabolism|May 1, 2015
Risk factors associated with hypovitaminosis D in HIV/aids-infected adultsJuliana Maria Palmeira Canuto, Virginia Maria Palmeira Canuto, Matheus Henrique Alves de Lima, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2003
Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancerDavid S Lamb, James W Denham, Hedy Mameghan, et al.
Pageof 27